Mechanism-based inhibition of ribonucleotide reductases: new mechanistic considerations and promising biological applications.
- 1 April 1999
- journal article
- review article
- Published by Taylor & Francis in Nucleosides and Nucleotides
- Vol. 18 (4) , 779-793
- https://doi.org/10.1080/15257779908041565
Abstract
Ribonucleotide reductases (RNRs) perform the de novo biosynthesis of 2′-deoxynucleoside 5′-(di or tri)phosphates. Inhibition of RNRs removes a crucial source of genetic components and enhances the probability of salvage incorporation of analogues into DNA. Several laboratories have clarified aspects of the reaction cascades initiated by generation of substrate nucleotide C3′ free radicals by RNRs. New considerations for radical-mediated mechanism-based inhibition and biological applications are discussed.Keywords
This publication has 58 references indexed in Scilit:
- Role of the M2 Subunit of Ribonucleotide Reductase in Regulation by Hydroxyurea of the Activity of the Anti-HIV-1 Agent 2′,3′-DideoxyinosineBiochemical Pharmacology, 1998
- DiscussionBiochemical Pharmacology, 1998
- Protein Radicals in Enzyme CatalysisChemical Reviews, 1998
- Ribonucleotide reductases — a group of enzymes with different metallosites and a similar reaction mechanismPublished by Springer Nature ,1997
- Ribonucleotide reductases: radical enzymes with suicidal tendenciesChemistry & Biology, 1995
- Ribonucleotide Reductase Targets for Chemotherapy; Mechanistic Aspects and Biologically Active AgentsNucleosides, Nucleotides and Nucleic Acids, 1995
- Structure of Ribonucleotide Reductase from Escherichia coliPublished by Springer Nature ,1995
- From RNA to DNA, Why So Many Ribonucleotide Reductases?Science, 1993
- The inhibition of ribonucleoside diphosphate reductase by hydroxyurea, guanazole and pyrazoloimidazole (IMPY)Pharmacology & Therapeutics, 1985
- Reduction of RibonucleotidesAnnual Review of Biochemistry, 1979